Category: 3. Business

  • Sumitomo Corporation of Americas Announces Strategic Investment in Independence Hydrogen to Develop Hydrogen Production and Distribution Projects

    Sumitomo Corporation of Americas Announces Strategic Investment in Independence Hydrogen to Develop Hydrogen Production and Distribution Projects

    NEW YORK and ASHBURN, Va., July 10, 2025 /PRNewswire/ — Sumitomo Corporation, through its U.S. subsidiary Sumitomo Corporation of Americas (collectively “Sumitomo Corporation Group”), announced a strategic investment in Independence Hydrogen to develop additional decentralized hydrogen production and distribution projects in the United States.

    Independence Hydrogen, Inc. is a veteran-founded and operated, privately held company that manufactures and distributes gaseous hydrogen in a decentralized hydrogen (DeHy®) business model. The company operates a hydrogen production facility in Petersburg, Virginia that recycles hydrogen, otherwise vented into the atmosphere as a waste product, into fuel cell grade hydrogen for customers in the material handling, mobility, remote critical infrastructure, and industrial gas sectors.

    Independence Hydrogen’s initial focus on smaller scale and decentralized hydrogen supply and transportation solves reliability and cost concerns, while offering speed to market. Hydrogen as a fuel has advantages in many applications, allowing for longer range, quick refueling, and no low-charge or environmental performance degradation.

    “Sumitomo Corporation Group has a long-term favorable view of hydrogen development,” said Tsutomu Sakamoto, General Manager of Energy Innovation Initiative Americas. “We strongly believe that Independence Hydrogen’s distributed business model approach will unlock growth in an underserved segment. We are confident that our robust collaboration with Suburban Propane and Hivers & Strivers will serve as a cornerstone for further expansion.” 

    “Sumitomo has a storied history of sustainable business success, and brings deep and broad experience in the energy, and specifically, hydrogen sector,” said Dat Tran, CEO of Independence Hydrogen. “We are extremely excited to work with Sumitomo, along with the expertise and support of our foundation investors, Suburban Propane and Hivers & Strivers, to accelerate the growth of our business.” 

    About Sumitomo Corporation
    Sumitomo Corporation (TYO: 8053) is an integrated trading company with a global network of 127 offices in 63 countries and regions. The Sumitomo Corporation Group consists of approximately 900 companies and 80,000 employees on a consolidated basis. The Group’s business activities span nine sectors: Steel, Automotive, Transportation & Construction Systems, Diverse Urban Development, Media & Digital, Lifestyle Business, Mineral Resources, Chemicals Solutions, and Energy Transformation Business. Sumitomo Corporation is dedicated to creating value for society under the corporate message of “Enriching lives and the world,” based on Sumitomo’s business philosophy passed down for over 400 years.

    About Sumitomo Corporation of Americas
    Established in 1952 and headquartered in New York City, Sumitomo Corporation of Americas has 9 offices in major U.S. cities, 4 in Canada, and 2 in Mexico. As the largest subsidiary of Sumitomo Corporation, Sumitomo Corporation of Americas is a key player in multinational projects, international investments, and global product distribution. Its core businesses include Energy, Automotive, Social Infrastructure, Agri-food and Life Science, Construction and Transportation Systems, Real Estate, Mineral Resources, and Energy Innovation.

    About Independence Hydrogen
    Independence Hydrogen regionally produces and distributes clean gaseous hydrogen in the United States. Independence Hydrogen’s mission is to make communities cleaner, safer, and more energy resilient by providing a reliable supply of affordable hydrogen with an end-to-end carbon intensity score. Our unique business model advances a standardized and scalable approach that offers speed to market, while lowering execution complexity and costs. More information about Independence Hydrogen can be found at www.independencehydrogen.com or https://ih2.us/. 

    About Suburban Propane Partners, L.P.
    Suburban Propane Partners, L.P. (“Suburban Propane”) is a publicly traded master limited partnership listed on the New York Stock Exchange. Headquartered in Whippany, New Jersey, Suburban Propane has been in the customer service business since 1928 and is a nationwide distributor of propane, renewable propane, renewable natural gas (“RNG”), fuel oil and related products and services, as well as a marketer of natural gas and electricity and producer of and investor in low carbon fuel alternatives, servicing the energy needs of approximately 1 million residential, commercial, governmental, industrial and agricultural customers through approximately 700 locations across 42 states. For additional information on Suburban Propane, please visit www.suburbanpropane.com.

    About Hivers & Strivers

    Hivers & Strivers invests in early-stage ventures led by U.S. military veterans. Since 2009 we have invested over $80 million in over 20 veteran-led ventures. Military veterans are an exceptional talent pool of leaders with grit, determination, and fierce execution skills. Hivers & Strivers believes that companies founded by military veterans will outperform peers.

    SOURCE Independence Hydrogen Inc.

    Continue Reading

  • Currency watch: Rupee ends 3 paise higher at 85.70 vs dollar; equities dip as tariff talks loom

    Currency watch: Rupee ends 3 paise higher at 85.70 vs dollar; equities dip as tariff talks loom

    The rupee ended 3 paise higher at 85.70 against the US dollar on Thursday, supported by optimism over a possible US-India trade deal, even as equity markets closed in the red.The local currency opened at 85.62 and moved between 85.53 and 85.70 during the session before settling 3 paise higher than Wednesday’s close of 85.73, according to interbank foreign exchange data, PTI reported.“Rupee traded with minor gains on a weak US dollar and an overnight decline in crude prices,” said Anuj Choudhary, research analyst at Mirae Asset Sharekhan. “However, weak domestic markets capped sharp gains.”Choudhary added that expectations of a US-India mini trade deal could support the rupee, though global sentiment remained cautious amid tariff uncertainties. He projected the USD-INR spot rate to remain in the Rs 85.40–85.95 range.On the trade front, a senior government official said a commerce ministry team will soon head to Washington for another round of negotiations. Talks are expected to address differences in sectors such as agriculture, automobiles, steel and aluminium.“We are negotiating a complete deal. Whatever is finalised can be packaged as an interim deal, and talks on the rest will continue,” the official said.India is also pushing for removal of additional import duties — 26 per cent on Indian goods — that the US has extended till August 1. It has reserved the right to impose retaliatory duties under WTO rules.Meanwhile, Brent crude fell 0.34% to $69.95 per barrel. The dollar index eased 0.15% to 97.41.In domestic markets, the Sensex dropped 345.80 points to 83,190.28, while the Nifty fell 120.85 points to 25,355.25. Foreign institutional investors were net buyers of Rs 221.06 crore in equities, according to exchange data.


    Continue Reading

  • YouTube cracks down on low-effort videos: Here’s all you need to know about the major changes this year

    YouTube cracks down on low-effort videos: Here’s all you need to know about the major changes this year

    YouTube will implement a new monetisation policy from July 15, 2025, aimed at limiting the earnings of channels that publish mass-produced, repetitive, or low-effort videos. The platform has updated its YouTube Partner Programme (YPP) guidelines to identify such content and prevent it from generating revenue.

    The year 2025 marks a decade of the content platform, which, according to Nielsen, has topped streaming watch time in the United States for two years. The platform has long advocated free speech and creative expression as part of its mission.

    Last year, more than 50% of channels earning five figures or more in US dollars on YouTube made money from sources other than ads and YouTube Premium. Shopping recommendations are also becoming a key revenue stream for many creators, with more than a 40% increase in channel memberships, the company said.

    Over the years, YouTube has been a voice to many. Whether it be Nikhil Kamath hosting a podcast with India’s Prime Minister Narendra Modi or Raj Shamani giving the first glimpse of Vijay Mallya nine years since the latter’s departure from the country.

    However, online content proliferating on the platform has also been a concern for a long time. According to a TOI report in January, tech companies, including Meta’s Facebook, Musk’s X, and Google’s YouTube, among others, have agreed to strengthen efforts against online hate speech under an updated code of conduct that will be incorporated into the European Union’s tech rules.

    Here’s the list of major updates by YouTube this year:

    July 2025: YouTube monetisation policy

    YouTube has outlined two specific rules that explain the kind of content the platform considers unfit for monetisation. First, content borrowed from other sources must be significantly altered to be considered original. Second, repetitive content must serve a purpose beyond gaining views. It must be either entertaining or educational.

    The updated monetisation policy continues to require creators to meet eligibility standards to join YPP. A channel must have at least 1,000 subscribers and either 4,000 valid public watch hours in the past year or 10 million valid public Shorts views in the last 90 days.

    June 2025: YouTube livestream

    YouTube updated the livestreaming rules, increasing the minimum age to be eligible to broadcast a livestream to 16 years. Earlier, the minimum age was 13. The rule will come into effect on July 22.

    June 2025: Moderation of videos

    YouTube allowed partial violation for ‘public interest’ content. Under this rule, content moderators are required to keep the videos online unless more than 50% of the content breaches YouTube’s policies. Earlier, it was a 25% threshold. In cases where free speech outweighs associated risks, such scenarios would be dealt with under YouTube’s existing EDSA framework.

    March 2025: Policy on content encouraging gambling

    YouTube in March announced an age restriction of 18 years for accessing content that depicts or promotes online betting sites. However, content related to online sports betting and in-person gambling will not be subject to these restrictions.

    Additionally, creators are also not allowed to direct viewers to any gambling sites or applications unless Google has certified them. With the new update, even the URLs, links embedded in images or text, visual displays (including logos), or verbal references are considered for checks.

    Continue Reading

  • Enzalutamide Plus Leuprolide Yields OS Benefit in nmHSPC With Biochemical Recurrence

    Enzalutamide Plus Leuprolide Yields OS Benefit in nmHSPC With Biochemical Recurrence

    nmHSPC | Image credit:

    © pikovit – stock.adobe.com

    Enzalutamide (Xtandi) combined with leuprolide generated a statistically significant and clinically meaningful improvement in overall survival (OS) vs placebo plus leuprolide in patients with nonmetastatic hormone-sensitive prostate cancer (nmHSPC; also known as nonmetastatic castration-sensitive prostate cancer [nmCSPC]) with high-risk biochemical recurrence at high risk for metastasis, meeting the key secondary end point of the phase 3 EMBARK trial (NCT02319837).1

    Top-line results from the OS analysis of EMBARK also showed a favorable trend toward improved OS for patients who received enzalutamide monotherapy vs placebo plus leuprolide, although this difference was not statistically significant. Detailed OS results from the EMBARK trial are planned to be presented at an upcoming medical conference.

    “These data demonstrate that treatment with [enzalutamide] can extend life for men with nmHSPC and high-risk biochemical recurrence who have relapsed after initial curative-intent therapy with prostatectomy, radiation therapy or both, further validating EMBARK’s metastasis-free survival [MFS] data,” Neal Shore, MD, FACS, of START Carolinas/Carolina Urologic Research Center in Myrtle Beach, South Carolina, stated in a news release. “While men with nmHSPC with high-risk biochemical recurrence now have expanded treatment choices, these results demonstrate a clear clinical benefit, including both MFS and OS, supporting the clinical practice of initiating [enzalutamide] for these patients.”

    The EMBARK investigators reported no new safety signals, and the safety findings were deemed consistent with the previously demonstrated safety profile of enzalutamide. Safety data from the initial analysis showed that the most common adverse effects (AEs) in the enzalutamide/leuprolide and placebo/leuprolide arms included fatigue and hot flashes. The most common AEs in the monotherapy arm were hot flashes, gynecomastia, and fatigue.

    “[Enzalutamide] is the only androgen receptor inhibitor–based regimen to demonstrate a survival benefit in metastatic HSPC and nmHSPC with high-risk biochemical recurrence, as well as castration-resistant prostate cancer, highlighting its significant patient impact in advanced prostate cancer,” Johanna Bendell, MD, oncology chief development officer of Pfizer, added in the news release. “These positive results add to the robust clinical support for the use of [enzalutamide] and broaden clinical confidence, offering men with high-risk biochemical recurrence evidence that they might live longer when they start [enzalutamide] early.”

    In the double-blind, multi-national EMBARK trial, 1068 patients with nmHSPC with high-risk biochemical recurrence were randomly assigned to receive enzalutamide at 160 mg daily plus leuprolide (n = 355), placebo plus leuprolide (n = 358), or enzalutamide monotherapy at 160 mg (n = 355).2 Data from the initial analysis, which were published in The New England Journal of Medicine in October 2023, showed that the study met its primary end point of a statistically significant and clinically meaningful improvement in MFS for patients who received enzalutamide plus leuprolide vs placebo plus leuprolide. The median follow-up of 60.7 months. The 5-year MFS rate was 87.3% (95% CI, 83.0%-90.6%) in the enzalutamide/leuprolide arm, 71.4% (95% CI, 65.7%-76.3%) in the leuprolide/placebo arm, and 80.0% (95% CI, 75.0%-84.1%) in the enzalutamide monotherapy arm. MFS outcomes with enzalutamide plus leuprolide were superior to those with leuprolide plus placebo (HR, 0.42; 95% CI, 0.30-0.61; P < .001). MFS outcomes with enzalutamide monotherapy were also superior to those with leuprolide plus placebo (HR, 0.63; 95% CI, 0.46-0.87; P = .005).

    Notably, in November 2023, the FDA approved enzalutamide for the treatment of patients with nmCSPC with biochemical recurrence at high risk for metastasis based on data from EMBARK.3

    “Over 1.5 million men with advanced prostate cancer around the world have benefited from treatment with [enzalutamide] since its initial approval in 2012,” Shontelle Dodson, executive vice president and head of Medical Affairs at Astellas, added in the news release.1 “The scope and rigor of the EMBARK trial exemplify Astellas’ and Pfizer’s longstanding commitment to the prostate cancer community, and we look forward to sharing detailed findings in a future scientific forum.”

    References

    1. Xtandi plus leuprolide significantly improves survival outcomes in men with non-metastatic hormone-sensitive prostate cancer with high-risk biochemical recurrence. News release. Pfizer Inc. July 10, 2025. Accessed July 10, 2025. https://investors.pfizer.com/Investors/News/news-details/2025/XTANDI-Plus-Leuprolide-Significantly-Improves-Survival-Outcomes-in-Men-with-Non-Metastatic-Hormone-Sensitive-Prostate-Cancer-with-High-Risk-Biochemical-Recurrence/default.aspx
    2. Freedland SJ, de Almeida Luz M, De Giorgi U, et al. Improved outcomes with enzalutamide in biochemically recurrent prostate cancer. N Engl J Med. 2023;389(16):1453-1465. doi:10.1056/NEJMoa2303974
    3. Pfizer and Astellas’ Xtandi approved by U.S. FDA in earlier prostate cancer treatment setting. News release. Astellas. Updated November 17, 2023. Accessed July 10, 2025. https://www.astellas.com/en/news/28626

    Continue Reading

  • Space startup Varda raises $187 million to make drugs in orbit

    Space startup Varda raises $187 million to make drugs in orbit

    Pavlo Gonchar | Lightrocket | Getty Images

    Space startup Varda announced on Thursday that it has raised $187 million in Series C funding, led by venture capital firms Natural Capital and Shrug Capital, to continue advancing drug manufacturing in space.

    The latest round included participation from Peter Thiel, Lux Capital, Khosla Ventures and Caffeinated Capital. It brought the total capital Varda’s raised to $329 million.

    “By expanding, we can support work on more complex molecules and ultimately increase cadence to achieve the turnaround times the pharmaceutical industry expects,” Chief Science Officer Adrian Radocea said in a press release Thursday.

    Varda’s main mission is to launch and return drugs made in space. The startup has said the medicines crystallize differently in orbit due to the gravity differences, which would allow it to complete drugs that are currently difficult to manufacture.

    In 2024, the space startup’s W-Series 1 capsule received FAA approval to return after successfully creating the drug Ritonavir the previous year.

    So far, Varda said the company has been able to complete three space launches. Now, a fourth is in orbit, and the company expects to launch a fifth by the end of the year. Varda’s system uses Rocket Lab’s Photon spacecraft for its operation and adds its manufacturing module and a heatshield-protected capsule.

    “With this capital, Varda will continue to increase our flight cadence and build out the pharmaceutical lab that will deliver the world’s first microgravity-enabled drug formulation,” said Varda CEO Will Bruey.

    Varda Space Industries is the first company to process materials outside the International Space Station.

    Recently, the space company has also operated a testbed for the U.S. government to use the W-series reentry vehicles to advance technology.

    Varda said it has expanded into Huntsville, Alaska, and opened a laboratory in El Segundo, California, to begin work to crystallize more drugs.

    “Our new lab space is an investment in our belief that in-space pharmaceutical manufacturing will drive the foundation of the orbital economy,” Radocea said.

    Continue Reading

  • Health care is trading at a big discount to the broader market. How to play it using options

    Health care is trading at a big discount to the broader market. How to play it using options

    Continue Reading

  • UAE ready for another oil capacity boost if markets require – Reuters

    1. UAE ready for another oil capacity boost if markets require  Reuters
    2. State giant poised to float tenders for expansion of world’s second-largest offshore oilfield  Upstream Online
    3. UAE stays course on five million barrels production capacity plan by 2027  thenationalnews.com
    4. UAE committed to achieving planned oil production capacity  Dubai Eye 103.8
    5. UAE remains focused on delivering its planned production capacity of 5 million barrels per day by 2027: Ministry of Energy and infrastructure – UAE BARQ  uaebarq.ae

    Continue Reading

  • FTSE 100 hits record high as investors shrug off trade war concerns | FTSE

    FTSE 100 hits record high as investors shrug off trade war concerns | FTSE

    The FTSE 100 index of the most valuable companies on the London Stock Exchange has soared to a new record high as investors shrugged off concerns over Donald Trump’s trade wars.

    The FTSE 100 had the 9,000-point mark in its sights on Thursday, as it climbed to 8,973 points, above its previous all-time high of 8,908 points.

    Stocks rose in London amid a global rally, as traders grew confident that Trump would either reach agreements with US trading partners, or again delay or dial back his threatened tariffs.

    Mining stocks led the FTSE 100 risers, with Anglo American up more than 5%, closely followed by Glencore and Rio Tinto.

    Victoria Scholar, the head of investment at Interactive Investor, said: “Commodities are fuelling the gains for the FTSE 100, with copper in the green and gold catching a bid on the back of a weaker US dollar.”

    The blue-chip share index has now risen by more than 9% during 2025, having recovered from sharp losses in early April when markets tumbled after Trump announced new tariffs on what he called “liberation day”, before recovering after he postponed them.

    The precious metals producer Fresnillo has been the top-performing FTSE 100 stock so far this year; its shares are up 140% since 1 January, driven by gains in the prices of gold and silver.

    The British defence company Babcock’s share price has doubled so far this year, while weapons-maker BAE Systems is up 63% year-to-date, helped by expectations of a surge in defence spending as the Russia-Ukraine war continued.

    Shares have pushed higher this week despite Trump announcing new tariff rates that will be imposed on imports from 1 August – postponed from a previous date of 9 July.

    Chris Beauchamp, the chief market analyst at IG, said investors were in an “ebullient summer mood”.

    “Perhaps most notable is the market’s apparent indifference to escalating trade tensions. Trump’s 50% tariff on copper imports and threats toward Brazil triggered little reaction. Many now view such announcements as political posturing, summed up by Taco: Trump always chickens out,” he said.

    skip past newsletter promotion

    Germany’s DAX share index also hit a record high on Thursday. It has gained more than 23% so far this year, lifted by plans from the German chancellor, Friedrich Merz, to increase government spending to drive investment and lift growth.

    The FTSE 100 is seen as a gauge of optimism about the world economy, as many of the largest companies listed in London have a global focus.

    Susannah Streeter, the head of money and markets at Hargreaves Lansdown, said: “The FTSE 100 is stuffed full of multinationals which are sensitive to the outlook for the world economy and with the so-called ‘Taco trade’ in full swing, it’s benefiting from more optimism around.

    “Investors expect that Trump will ‘chicken out’ from imposing his threat,” Streeter added.

    Continue Reading

  • Trade, tariffs, and supply chain shocks: Risk engineers as strategic lookouts for the energy and power sector

    Trade, tariffs, and supply chain shocks: Risk engineers as strategic lookouts for the energy and power sector

    The recent imposition of tariffs and reciprocal tariffs by the US and other trading nations, even with exemptions for certain commodities, has created uncertainty across the energy and power sectors. Key inputs such as steel, aluminum, and machinery are facing price surges in some economies and supply reductions in others, leading to a substantial shift in the cost structure of capital-intensive projects. Additionally, trade diversion is causing supply gluts in some markets, leading to price decreases and further complicating the landscape.

    While the direct effects of tariffs can be modeled, anticipating indirect effects — such as changes in construction costs, equipment pricing, profit margins, investment behaviors, and market reactions — remains complex. As macroeconomic risks evolve into physical risks, energy and power companies can benefit from risk engineering insights and strategies to effectively manage their exposures, assess their insurance coverage limits, and understand potential premium impacts.

    How tariffs and trade uncertainty are changing the risk landscape for the energy and power sector

    Today’s macroeconomic landscape presents several complex challenges for the energy and power sector and the risk engineers supporting it, including:

    • Equipment supply chain delays, which may increase rebuild times and business interruption (BI) indemnity periods.
    • Changes in asset valuation due to fluctuating input prices, which may increase re/build estimates and final costs.
    • Reduced project viability as cost increases pressure return on investment models, especially for refining, hydrogen, and chemical projects.
    • Extended project timelines, affecting assumptions in delay in start-up (DSU) and BI limits.
    • Recalibration of loss prediction models to account for turnaround deferrals and latent risks that may arise years later.

    Many of today’s risks associated with supply chain disruptions, cost increases, and potential legal, insurance, and contractual issues, are not new. Insights from risk engineers, drawing on experience during previous periods of macroeconomic volatility, can provide valuable guidance for addressing the challenges faced by the energy and power sector today.

    What risk engineers learned from past macroeconomic volatility

    Previous crises, such as the 2014 oil price crash, the 2008 financial collapse, and the 2020 COVID-19 pandemic, illustrated how systemic shocks can undermine operational continuity in the energy and power sector. For example:

    • The oil price collapse in 2014 led to widespread reductions in engineering budgets, particularly in the oil and gas industry, accelerating the demand for cost-effective, data-driven engineering approaches.
    • The 2008-2009 financial crisis saw many energy and power companies increase their BI coverage after experiencing liquidity challenges.
    • During the COVID-19 pandemic, deferred maintenance and project postponements initially reduced loss frequency. However, over time this led to an increase in mechanical failures and breakdowns due to degraded asset performance.

    These past events underscore the importance of sustained collaboration between risk engineers, brokers, and underwriters throughout the lifecycle of an insured asset, rather than limiting engagement to initial placements. Today’s supply chain challenges could potentially have broader and more persistent consequences than previous financial crises.

    Revisiting business interruption and supply chain risk models

    Today’s logistical disruptions, cost constraints, and scarcity of critical components may lead to a mismatch between modeled reinstatement durations, BI indemnity periods, and rebuild timelines.

    In both conventional and renewable energy technologies, emerging focus areas for risk engineers may include:

    • Uncertain rebuild times resulting from the temporary unavailability of specific original equipment manufacturer (OEM) components, particularly those with few substitutes, could extend outage periods beyond current assumptions.
    • Supply chain rerouting, especially away from the US or China, may initially reduce prices, but could increase lead times and uncertainty, particularly for companies sourcing specialized transformers, turbines, compressors, or control systems.
    • Outdated asset valuations may no longer reflect current replacement costs.
    • Business interruption timelines may be longer than expected due to procurement delays.
    • Tariff-induced foreign direct investment (FDI) shifts that may lead companies to pursue regional manufacturing options. This could take time and create a near-term gap in reliable sourcing, although political risk insurance could be useful depending on the political risk level in any new jurisdiction.

    Furthermore, there is the potential for deferred losses. Reduced loss frequency, due to idle capacity or postponed operations, may create a false sense of security. Historical trends, as noted above, suggest that this could lead to concentrated loss activity once operations resume without full mechanical integrity restoration.

    The effects extend beyond equipment. Changes in global commodity flows are likely to alter supply chains, potentially creating new vulnerabilities and a need to reassess contingent business interruption coverage. Changes in profitability stemming from macroeconomic shifts directly influence BI values, making it key to assess the impacts on insurance coverage.

    Risk engineers can assist in analyzing the business impacts and help reframe BI planning with updated assumptions. Sharing these findings with insurers can help make desired adjustments to coverage.

    Navigating financial pressures and operational risks

    Refining and petrochemical operators are particularly vulnerable to fluctuations in feedstock costs and demand for end products. If tariffs suppress demand for downstream goods or energy end-use sectors, such as transportation and manufacturing, plant utilization can suffer. In response, operators may choose to:

    • Defer capital investments.
    • Delay critical maintenance turnarounds.
    • Operate with minimal staffing levels.
    • Acquire cheaper feedstocks.

    Any operational adjustment will require risk engineers to adapt their assessments of fire protection, mechanical integrity, and emergency response planning, while applying a robust management of change (MoC) system.

    Downstream maintenance deferrals

    When equipment strategies and risk-based inspection (RBI) plans are optimized for a specific cycle, making last-minute changes due to financial pressures can jeopardize overall business health. The potential for unexpected equipment failures or accumulation of functional failures can result in significant costs down the line.

    For smaller operators facing financial constraints, deferring turnarounds may seem unavoidable. However, it is crucial to implement robust deferral mitigation plans and carefully consider any scope reductions to minimize adverse impacts. This process should involve a cross-functional team, including operations, to gain a comprehensive understanding of the risks involved.

    Balancing capacity, cost, and complexity in power generation

    Mothballing older or less reliable power plant units can yield risk management and operational efficiency benefits. By temporarily taking these units offline, operators can reduce the frequency of losses associated with equipment failures and operational stress. This strategic approach can enhance the overall reliability of remaining active units and allow for refocused allocation of resources towards maintaining and optimizing more dependable assets.

    Renewables projects face additional complexity from rapid changes in equipment prices and global political uncertainty, which can impact project schedules and financing.

    In the context of renewables, maintaining the supply-demand balance between operating renewable energy sources and traditional power generation can help mitigate strategic risks. Unlike previous challenging periods, the current environment may limit options for rapid adjustments in energy sourcing, highlighting the importance of a diverse energy portfolio that can adapt to demand fluctuations while promoting reliability.

    How risk engineers can help mitigate risk

    Today’s risk engineers operate at the intersection of technical integrity, financial viability, and strategic foresight. Their role can extend beyond traditional inspections to include:

    • Advising on asset valuations using current market indices and global cost trends.
    • Developing realistic rebuild timelines and inflation risks.
    • Contributing technical insights to enterprise-level risk assessments.
    • Supporting companies and their teams in pursuing more favorable insurance outcomes by articulating risk improvements and resilience strategies.

    In this way, risk engineers have become vital partners in shaping the future of risk management across specialty markets.

    To respond effectively to emerging macroeconomic risks, risk engineers can collaborate with companies and their insurance teams across five key areas:

    1. Proactive engagement: Initiate early discussions around valuation accuracy, equipment lead times, and the potential impact of deferral strategies.
    2. Enhanced BI modeling: Refine BI assumptions to account for extended downtime, temporary fixes, and inflationary pressures.
    3. Scenario-based dialogue: Help to illustrate to key stakeholders how economic volatility may affect plant availability and asset risk.
    4. Technical review: Develop engineering risk reports that can be used to highlight operational resilience and assist in pursuing desired coverage.
    5. Investment in predictive tools: Develop risk heatmaps, maintenance datasets, and early indicators to flag deteriorating asset conditions.

    These actions can equip energy and power companies to pursue insurance placements that are structured for resilience amid uncertain conditions.

    Determining your own risk mitigation strategies

    Energy and power companies face various challenges and risks as the macroeconomic environment remains volatile. By involving risk engineers as early as possible in the design, construction, operation, and decommissioning of assets, and using their expertise effectively, you can better mitigate and manage your cost of risk.

    Continue Reading

  • Wabtec and IMT Sign Exclusive Agreement to Distribute Railcar Telematics in European Markets

    Wabtec and IMT Sign Exclusive Agreement to Distribute Railcar Telematics in European Markets

    PARIS, July 10, 2025 – Wabtec Corporation (NYSE: WAB) and Intermodal Telematics B.V. (IMT), the Dutch leader in rail telematics technology, today announced an agreement expanding the exclusive distribution rights to include the European market. This agreement makes Wabtec the exclusive distributor of IMT’s telematics solutions for railcars in the major European freight markets. It also leverages IMT’s advanced technology and Wabtec’s market presence to deliver smart, connected railcar solutions across Europe.

    This partnership is a step forward in Wabtec’s digital transformation strategy, aimed at providing fully integrated, data-driven solutions that optimize rail operations. By combining IMT’s telematics expertise with Wabtec’s in-depth knowledge of braking systems and rail technology, the two companies will offer their customers smarter maintenance, enhanced safety and improved operational efficiency.

    “This agreement aligns two strong players in the rail industry and opens the door for large-scale telematics deployment in Europe and sets the basis for continuous developments of digital-based solutions to enhance efficiency, performance, service reliability, and safety,” said Dethmer Drenth, Managing Director of IMT. “Our proven technology will be supported by Wabtec’s extensive network and customer relationships, enabling rail operators to benefit from real-time data and increased visibility across their fleets.”

    Wabtec’s European telematics offering will include IMT’s full suite of sensors, gateways, and connectivity solutions, enabling real-time monitoring of location, load status, and critical components such as brake system. The agreement includes dedicated support, performance targets, and long-term service continuity commitments.

    “This emerging technology in the rail industry unlocks powerful, real-time information for customers regarding location, condition, and health,” said Evan Sevel, Wabtec Vice President of Growth and Innovation.

    According to Cédric Lebrat, Vice President UIC Freight Components Product Line: “The opportunity to turn the European fleet of railcars into smart, connected assets by using this technology is a game changer, one capable of tilting the customer-experience balance back in favor of rail and, with it, driving a major modal shift.”

    The collaboration builds on IMT’s track record in tank container monitoring and extends its innovation to freight rail under the Wabtec brand, creating new efficiencies and value for the European rail sector.

    About Intermodal Telematics (IMT)
    Headquartered in Breda, The Netherlands, IMT is a global innovator in telematics for tank containers and railcars. With a strong focus on reliability, data accuracy, and seamless integration, IMT provides smart asset solutions that enhance safety, operational efficiency, and supply chain visibility.

    About Wabtec   
    Wabtec Corporation is revolutionizing the way the world moves for future generations. The Company is a leading global provider of equipment, systems, digital solutions and value-added services for the freight and transit rail industries, as well as the mining, marine and industrial markets. Wabtec has been a leader in the rail industry for 155 years and has a vision to achieve a sustainable rail system in the U.S. and worldwide. Visit Wabtec’s website at http://www.wabteccorp.com.

    Continue Reading